Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

F-star Alpha spins out of F-star GMBH; raises €9.4mm through Series A round

Executive Summary

Austrian cancer company F-star GMBH has spun out some of its oncology assets into F-star Alpha Ltd. The new independent company concurrently raised €9.4mm ($12.9mm) through a Series A round from Atlas Venture, Asecap Venture, TVM Capital, SR One, MP Healthcare Venture Management, and MS Ventures (formerly Merck Serono Ventures). F-star Alpha’s first preclinical project in-licensed from its originator is FS102 for breast, gastric, and colorectal cancers.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Spin-Off

Related Companies